```html

Digitalis Toxicity – A Comprehensive Medical Guide

Overview

Digitalis toxicity (also called digoxin or digitoxin poisoning) occurs when the concentration of cardiac glycosides in the blood becomes high enough to cause harmful physiological effects. These drugs—most commonly digoxin—are prescribed for heart failure, atrial fibrillation, and certain supraventricular tachyarrhythmias.

• Who it affects: Adults, especially older adults (≥65 years), patients with chronic kidney disease, hypothyroidism, or electrolyte disturbances (low potassium or magnesium).
• Prevalence: In the United States, digoxin is prescribed to ~5 % of patients with heart failure. Toxicity accounts for 2–5 % of all digoxin‐related emergency department visits each year (CDC, 2022). The incidence rises to ≈ 12 % among patients with advanced renal impairment.

Symptoms

Symptoms may appear within hours of an overdose or gradually with accumulation. The spectrum ranges from mild nausea to life‑threatening arrhythmias.

Gastrointestinal

• Nausea & vomiting – often the earliest sign.
• Loss of appetite and a feeling of fullness.
• Abdominal pain or cramping.
• Diarrhea – less common but reported.

Neurologic / General

• Fatigue or weakness – may be mistaken for worsening heart failure.
• Confusion, delirium, or visual disturbances (e.g., halos, yellow‑green “xanthopsia”).
• Headache or dizziness.

Cardiovascular

• Bradycardia (heart rate < 60 bpm) – most common serious sign.
• Premature ventricular contractions (PVCs) and other ectopic beats.
• AV‑block (first‑, second‑, or third‑degree).
• Atrial tachycardia with block – classic but rare.
• Ventricular tachycardia or fibrillation – life‑threatening.
• Palpitations or sensation of “skipped beats.”

Other

• Hyperkalemia (elevated serum potassium) – both a sign and a cause of worsening toxicity.
• Electrolyte imbalances – especially low potassium or magnesium that predispose to arrhythmias.

Causes and Risk Factors

Primary Causes

• Therapeutic overdose – taking a higher dose than prescribed.
• Acute accidental ingestion – accidental swallowing of the medication or of plant sources (e.g., foxglove).
• Drug interactions – medications that increase digoxin levels (e.g., amiodarone, quinidine, verapamil, macrolide antibiotics, certain antifungals, and some diuretics).
• Impaired elimination – reduced renal clearance in chronic kidney disease, acute kidney injury, or in the elderly.

Risk Factors

• Age ≥ 65 years.
• Renal insufficiency (eGFR < 60 mL/min/1.73 m²).
• Electrolyte disturbances – especially hypokalemia, hypomagnesemia, or hyperkalemia.
• Hypothyroidism (decreases digoxin metabolism).
• Concurrent use of P‑glycoprotein inhibitors (e.g., verapamil, quinidine).
• Dehydration or high‑dose diuretic therapy leading to volume depletion.
• Genetic polymorphisms affecting digoxin transport (rare).

Diagnosis

Diagnosis is a combination of clinical suspicion, laboratory testing, and cardiac monitoring.

History & Physical Examination

• Recent digoxin prescription changes, missed doses, or new interacting drugs.
• Symptoms matching the list above, especially visual changes (“yellow‑green halos”).
• Vital signs: bradycardia, hypotension, arrhythmias.

Laboratory Tests

• Serum digoxin concentration (SDC) – therapeutic range: 0.5–2.0 ng/mL (0.6–2.5 nmol/L) for heart failure; levels > 2.0 ng/mL usually indicate toxicity.
• Electrolytes – potassium, magnesium, calcium.
• Renal function – serum creatinine, eGFR.
• Thyroid function tests – TSH, free T4.
• Serum potassium – hyper‑ or hypokalemia may both be present.

Cardiac Evaluation

• 12‑lead ECG – look for characteristic arrhythmias, PR‑interval prolongation, scooped ST‑segments (“digitalis effect”).
• Continuous cardiac telemetry in an emergency or monitored setting.

Imaging (rarely needed)

• Chest X‑ray if pulmonary edema is suspected from concurrent heart failure.

Treatment Options

Treatment is aimed at stabilizing the heart rhythm, correcting electrolyte disturbances, and removing excess digoxin.

Immediate Measures

• Discontinue digoxin immediately.
• Place the patient on a cardiac monitor; obtain IV access.
• Correct electrolyte abnormalities (e.g., give potassium if low, but avoid rapid over‑correction if hyperkalemic).

Antidote – Digoxin‑Specific Antibody Fragments

Commercially known as Digibind® (ovine Fab fragments) or Digifab® (human Fab). Indications include:

• Life‑threatening arrhythmias or hemodynamic instability.
• Serum digoxin > 2.5 ng/mL with symptoms.
• Hyperkalemia > 5.5 mmol/L secondary to digoxin toxicity.

Typical dose: 400 mg IV bolus; additional doses may be required based on repeat SDC.

Arrhythmia Management

• Bradycardia / AV‑block – temporary pacing if symptomatic, especially if heart rate < 40 bpm or hypotensive.
• Ventricular arrhythmias – magnesium sulfate 2 g IV over 10 min; lidocaine if needed; avoid calcium channel blockers.
• Atrial tachycardia with block – treat with quinidine or procainamide; avoid AV‑node blockers.

Supportive Care

• IV fluids for hypotension (cautiously, as volume overload may worsen heart failure).
• Oxygen or non‑invasive ventilation if respiratory distress.
• Management of concurrent heart failure per guideline‑directed therapy.

Removal of Digoxin (rarely needed)

• Hemodialysis is ineffective because digoxin is highly protein‑bound.
• Charcoal hemoperfusion can be considered in massive acute ingestions, but data are limited.

Long‑Term Adjustments

• Re‑evaluate digoxin dose; many patients can be maintained on a lower dose or discontinued entirely.
• Switch to alternative rate‑control agents (e.g., beta‑blockers, diltiazem) when appropriate.

Living with Digitalis Toxicity

Even after an acute episode, patients often continue on digoxin or a similar cardiac glycoside, making vigilance essential.

• Medication reconciliation – keep an up‑to‑date list; share with every prescriber.
• Regular lab monitoring – check serum digoxin, electrolytes, and renal function at least every 3 months or sooner after any dose change.
• Adherence – take the medication exactly as prescribed; use a pill organizer or alarms.
• Hydration – avoid dehydration; maintain adequate fluid intake unless restricted by heart failure.
• Dietary considerations – limit high‑potassium foods if you have hyperkalemia; converse with your clinician about safe ranges.
• Recognize early signs – nausea, visual changes, or new palpitations should prompt an immediate call to your provider.
• Wear medical identification – a card or bracelet noting “digoxin user” can guide emergency care.

Prevention

• Prescribe the lowest effective dose; start at ≤0.125 mg daily for most adults.
• Screen for renal impairment before initiating therapy and adjust dose accordingly.
• Check baseline electrolytes and thyroid function; correct abnormalities before starting digoxin.
• Educate patients on drugs that interact with digoxin (e.g., certain antibiotics, antiarrhythmics, NSAIDs).
• Use electronic prescribing alerts and pharmacy checks to catch dangerous drug‑drug interactions.
• Encourage routine follow‑up visits within 1–2 weeks after any dose change.

Complications

If untreated, digitalis toxicity can lead to serious, sometimes irreversible outcomes.

• Life‑threatening arrhythmias – ventricular fibrillation is the most fatal.
• Heart failure exacerbation due to bradyarrhythmia or loss of inotropic support.
• Stroke – from atrial fibrillation with rapid ventricular response.
• Renal failure – both a cause and consequence of toxicity.
• Neurologic sequelae – prolonged confusion or visual deficits.
• In severe cases, mortality rates range from 5 % to 10 % despite treatment (Mayo Clinic, 2023).

When to Seek Emergency Care

---

Sources: Mayo Clinic; Centers for Disease Control and Prevention (CDC); National Institutes of Health (NIH) – National Heart, Lung, and Blood Institute; American College of Cardiology (ACC) Guidelines; World Health Organization (WHO); Cleveland Clinic. All information is for educational purposes and does not replace professional medical advice.

```